| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 798 |
| 1 | PREDNISOLONE | 602 |
| 2 | PREDNISOLONE ORAL | 602 |
| 3 | PREDNISOLONE ORAL SOLUTION | 602 |
| 4 | TACROLIMUS | 568 |
| 5 | METHOTREXATE SODIUM | 550 |
| 6 | RITUXIMAB | 545 |
| 7 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 521 |
| 8 | MYCOPHENOLATE MOFETIL | 520 |
| 9 | METHOTREXATE | 508 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | INFLIXIMAB-DYYB | 83 | 0.0241 |
| 1 | VANCOMYCIN HYDROCHLORIDE | 161 | 0.0193 |
| 2 | BARICITINIB | 55 | 0.0180 |
| 3 | ERGOCALCIFEROL | 318 | 0.0107 |
| 4 | GOLIMUMAB | 132 | 0.0105 |
| 5 | AMOXICILLIN AND CLAVULANATE POTASSIUM | 46 | 0.0101 |
| 6 | REMDESIVIR | 124 | 0.0093 |
| 7 | HUMAN IMMUNOGLOBULIN G | 153 | 0.0073 |
| 8 | TAZOBACTAM SODIUM AND PIPERACILLIN SODIUM | 48 | 0.0071 |
| 9 | VONOPRAZAN FUMARATE | 57 | 0.0070 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 2195 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 861 |
| 2 | CD20-directed Cytolytic Antibody [EPC] | 671 |
| 3 | Tumor Necrosis Factor Blocker [EPC] | 633 |
| 4 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 550 |
| 5 | Proton Pump Inhibitor [EPC] | 542 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 540 |
| 7 | Loop Diuretic [EPC] | 519 |
| 8 | Kinase Inhibitor [EPC] | 504 |
| 9 | Alkylating Drug [EPC] | 489 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 103 | 0.1497 |
| 1 | CXC Chemokine Receptor 4 Antagonist [EPC] | 1 | 0.1250 |
| 2 | CD38-directed Cytolytic Antibody [EPC] | 105 | 0.0179 |
| 3 | Provitamin D2 Compound [EPC] | 318 | 0.0107 |
| 4 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 124 | 0.0093 |
| 5 | Human Immunoglobulin G [EPC] | 179 | 0.0085 |
| 6 | Complement C5 Inhibitor [EPC] | 1 | 0.0083 |
| 7 | Complement Factor D Inhibitor [EPC] | 2 | 0.0065 |
| 8 | Guanylate Cyclase-C Agonist [EPC] | 13 | 0.0063 |
| 9 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 23 | 0.0057 |